Screening for atrial fibrillation
51 results
1 - 51
Screening for atrial fibrillation 
Systematic screening for the detection of atrial fibrillation
Screening for atrial fibrillation in primary care is not effective (VITAL-AF)- USPSTF 2022 concludes evidence is insufficient to recommend screening for asymptomatic atrial fibrillation (I statement)
- Screening high-risk patients for atrial fibrillation with implantable loop recorder does not prevent stroke or systemic emboli (LOOP)
- Prevention of atrial fibrillation
- Automated devices detect only 67% to 83% of patients with atrial fibrillation
- The prognosis is similar for adults with symptomatic versus asymptomatic atrial fibrillation
- ACC/AHA guidelines for the diagnosis and management of atrial fibrillation
- USPSTF 2018: insufficient evidence to recommend screening for AFib with ECG (I statement)
- Symptoms of arrhythmia and examination of an arrhythmia patient
- Treatment approach for atrial fibrillation: rate control or rhythm control?
- Concomitant atrial fibrillation surgery for people undergoing cardiac surgery
- Hyperthyroidism as a risk factor for atrial fibrillation
- Intensive cardiovascular screening has little benefit in older men (DANCAVAS)
- Clinical service organisation for adults with atrial fibrillation
- Hypertrophic cardiomyopathy
- Screening for thyroid disease and treatment of subclinical hypothyroidism
- Low-intensity warfarin may be inferior to standard-intensity warfarin for preventing VTE after joint arthroplasty
- Evaluation of thrombophilia
- Zoledronic acid reduces asymptomatic fractures but not clinical ones in men
- Ambulatory ECG monitoring
- Interrupted versus uninterrupted anticoagulation therapy for catheter ablation in adults with arrhythmias
- Warfarin therapy